文献速递衰弱、肌少症与跌倒老年慢病共病管理

临床衰弱独立预测缺血性卒中后早期死亡

Clinical frailty independently predicts early mortality after ischaemic stroke.
PubMed 文献 · Age Ageing · 2020-01-01

研究纳入433例≥75岁缺血性卒中住院患者,用临床衰弱量表(CFS)评估衰弱,发现衰弱组28天死亡率显著高于非衰弱组,且CFS每增加1分与28天死亡率独立相关;在63例溶栓患者中,衰弱者溶栓后NIHSS改善不明显。

要点

  • ≥75岁缺血性卒中患者中,衰弱组28天死亡率16.7%,非衰弱组5%。
  • 衰弱者溶栓后NIHSS改善受限,CFS每增1分与NIHSS改善减少1分独立相关。

核心结论

  • 临床衰弱与缺血性卒中后28天死亡率独立相关,并可能独立关联溶栓后NIHSS改善减弱。

研究设计与样本

  • 回顾性研究,纳入433例≥75岁缺血性卒中住院患者,用CFS评估衰弱,NIHSS评估卒中严重程度,收集28天死亡率和临床结局。

主要发现

  • 衰弱组28天死亡39例(16.7%),非衰弱组10例(5%),P<0.01。
  • 63例溶栓患者中,非衰弱者NIHSS中位数从12.5(IQR 9.25)降至5(IQR 10.5),P<0.01;衰弱者从15(IQR 11.5)至16(IQR 16.5),P=0.23。
  • 多变量分析中,CFS每增加1分与溶栓后NIHSS改善减少1分独立相关(系数1.07,P=0.03)。

关键数值与推荐

  • 衰弱定义:CFS 5-8分为衰弱,CFS 1-4分为非衰弱;同时将CFS作为连续序数量表分析。

临床怎么用

  • 对≥75岁缺血性卒中患者,可用CFS评估衰弱以辅助预测28天死亡风险。
  • 对衰弱患者溶栓决策时,需考虑其NIHSS改善可能有限。

局限性

  • 回顾性研究设计,样本量有限(溶栓亚组仅63例),需进一步研究阐明机制及衰弱在临床决策中的应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinical frailty is an important syndrome for clinical care and research, independently predicting mortality and rates of institutionalisation in a range of medical conditions. However, there has been little research into the role of frailty in stroke. OBJECTIVE: This study investigates the effect of frailty on 28-day mortality following ischaemic stroke and outcomes following stroke thrombolysis. METHODS: Frailty was measured using the Clinical Frailty Scale (CFS) for all ischaemic stroke admissions aged ≥75 years. Stroke severity was measured using the National Institutes of Health Stroke Scale (NIHSS). 28-day mortality and clinical outcomes were collected retrospectively. Analysis included both dichotomised measures of frailty (non-frail: CFS 1-4, frail: 5-8) and CFS as a continuous ordinal scale. RESULTS: In 433 individuals with ischaemic stroke, 28-day mortality was higher in frail versus non-frail individuals (39 (16.7%) versus 10 (5%), P < 0.01). On multivariable analysis, a one-point increase in CFS was independently associated with 28-day mortality (OR 1.03 (1.01-1.05)). In 63 thrombolysed individuals, median NIHSS reduced significantly in non-frail individuals (12.5 (interquartile range (IQR) 9.25) to 5 (IQR 10.5), P < 0.01) but not in frail individuals (15 (IQR 11.5) to 16 (IQR 16.5), P = 0.23). On multivariable analysis, a one-point increase in CFS was independently associated with a one-point reduction in post-thrombolysis NIHSS improvement (coefficient 1.07, P = 0.03). CONCLUSION: Clinical frailty is independently associated with 28-day mortality after ischaemic stroke and appears independently associated with attenuated improvement in NIHSS following stroke thrombolysis. Further research is needed to elucidate the underlying mechanisms and how frailty may be utilised in clinical decision-making.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Evans NR, Wall J, To B, et al. Clinical frailty independently predicts early mortality after ischaemic stroke. Age Ageing. 2020. PMID: 31951248. doi:10.1093/ageing/afaa004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。